The incubator is designed to draw cell and gene therapy researchers and drugmakers to work at the hub, where they can develop ...

Advancements in organoid technology are crucial for Parkinson's disease research, providing human-relevant models for ...

Discoverer of Klotho gene further strengths KLTO Scientific Advisory BoardNEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and ...

(Alliance News) - Syncona Ltd on Wednesday noted positive trial results for a portfolio company's gene therapy aimed at treating people with Gaucher's disease.

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf neuron replacement therapies for neurological ...

We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...

Unprecedented genome analysis ties brain structure variations to genetic risks for Parkinson’s disease and ADHD ...

The world’s largest genetic study on the size of specific brain parts has revealed hundreds of clues about how some health ...

"Everything we currently we know about disease is rooted in a genetic variant in a gene, and that is because that genetic ...

A team of scientists has discovered surprising connections among gene activity, genome packing, and genome-wide motions, ...